p53, p21, Rb, and MDM2 proteins in tongue carcinoma from patients <35 versus >75 years

Oral Oncology

Volumn 35, Issue 4, 1999, Pages 379-383

  Regezi, J A ^a   Dekker, N P ^a   McMillan, A ^a   Ramirez Amador, V ^b   Meneses Garcia, A ^c   Ruiz Godoy Rivera, L M ^c   Chrysomali, E ^d   Ng, I O L ^e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b DEPARTAMENTO DE SISTEMAS BIOLÓGICOS   (Mexico)

^c Instituto National de Cancerologia   (Mexico)

^d UNIVERSITY OF ATHENS   (Greece)

^e UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Cell cycle; MDM2; Mouth; P21; P53; Retinoblastoma protein; Squamous cell carcinoma

Indexed keywords

PROTEIN MDM2; PROTEIN P21; PROTEIN P53; RETINOBLASTOMA PROTEIN;

ADULT; AGED; ARTICLE; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; SCORING SYSTEM; SQUAMOUS CELL CARCINOMA; TONGUE CARCINOMA;

EID: 0033168334     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1368-8375(98)00126-2     Document Type: Article

References (28)

1. Cusumano R.J., Persky M.S. Squamous cell carcinoma of the oral cavity and oropharynx in young adults. Head and Neck Surgery. 10:1988;229-234.
2. Jones J.B., Lampe H.B., Cheung H.W. Carcinoma of the tongue in young patients. Journal of Otolaryngology. 18:1989;105-108.
3. Schantz S.P., Byers R.M., Goepfert H., Shallenberger R.C., Beddingfield R.N. The implication of tobacco use in the young adult with head and neck cancer. Cancer. 62:1988;1374-1380.
4. Siegelmann N., Hanlon A., Ridge J.A.et al. Oral tongue cancer in patients less than 45 years old: institutional experience and comparison with older patients. Journal of Clinical Oncology. 16:1998;745-753.
5. Friedlander P.L., Schantz S.P., Shaha A.R., Yu G., Shah J.P. Squamous cell carcinoma of the tongue in young patients: a matched-pair analysis. Head and Neck. 20:1998;363-368.
6. Goodger N.M., Gannon J., Hunt T., Morgan P.R. Cell cycle regulatory proteins - an overview with relevance to oral cancer. Oral Oncology. 33:1997;61-73.
7. De Araujo V.C., Loyola A.M., Santos Pinto Jr D.D., Borra R.C., De Araujo N.S. p53 in biopsies of oral squamous cell carcinoma. A comparative study with a malignancy grading system. Oral Oncology. 33:1997;5-9.
8. Kropveld A., van Mansfield A.D. M., Nabben N., Hordijk G.J., Slootweg P.J. Discordance of p53 status in matched primary tumours and metastases in head and neck squamous cell carcinoma patients. Oral Oncology, European Journal of Cancer. 6:1996;388-393.
9. Mineta H., Borg A., Dictor M., Wahlberg P., Wennerberg J. Correlation between p53 mutation and cyclin D1 amplification in head and neck squamous cell carcinoma. Oral Oncology. 33:1997;42-46.
10. Girod S.C., Cesarz D., Fischer U., Krueger G.R. F. Detection of p53 and MDM2 protein expression in head and neck carcinogenesis. Anticancer Research. 15:1995;1453-1458.
11. Matsumura T., Yoshihama Y., Kimura T., Shintani S., Alcalde R.E. p53 and MDM2 expression in oral squamous cell carcinoma. Oral Oncology. 53:1996;308-312.
12. Ng I.O.L., Lam K.Y., Ng M., Regezi J.A. Expression of p21/waf1 in oral squamous cell carcinomas - correlation with p53 and MDM2 genes and cellular proliferation. Oral Oncology, in press.
13. Agarwal S., Mathur M., Shukla N.K., Ralhan R. Expression of cyclin dependent kinase inhibitor p21 in premalignant and malignant oral lesions: relationship with p53 status. Oral Oncology. 34:1998;353-360.
14. Schoelch M.L., Regezi J.A., Dekker N.P., et al. Cell cycle proteins and the development of oral squamous cell carcinoma. Oral Oncology, in press.
15. van Oijen M.G. C. T., Tilanus M.G. J., Medema R.H., Slootweg P.J. Expression of p21 (Waf1/Cip1) in head and neck cancer in relation to proliferation, differentiation, p53 status and cyclin D1 expression. Journal of Oral Pathology and Medicine. 27:1998;367-375.
16. Warnakulasuriya K.A. A. S., Tavassoli M., Johnson N.W. Relationship of p53 overexpression to other cell cycle regulatory proteins in oral squamous cell carcinoma. Journal of Oral Pathology and Medicine. 27:1998;376-381.
17. Yook J.I., Kim J. Expression of p21 WAF1/CIP1 in unrelated to p53 tumour suppressor gene status in oral squamous cell carcinomas. Oral Oncology. 34:1998;198-203.
18. Pande P., Mathur M., Shukla N.K., Ralhan R. pRb and p16 protein alterations in human oral tumorigenesis. Oral Oncology. 34:1998;396-403.
19. Pavelic Z.P., Lasmar M., Pavelic L., Sorensen C., Stambrook P.J.et al. Absence of retinoblastoma gene product in human primary oral cavity carcinomas. Oral Oncology, European Journal of Cancer. 32B:1996;347-351.
20. Xu J., Gimenez-Conti I.B., Cunningham J.E.et al. Alterations of p53, cyclin D1, Rb, and H-ras in human oral carcinomas related to tobacco use. Cancer. 83:1998;204-212.
21. Yokoyama J., Shiga K., Sasano H., Suzuki M., Takasaka T. Abnormalities and the implication of retinoblastoma locus and its protein product in head and neck cancers. Anticancer Research. 16:1996;641-644.
22. Bartek J., Bartkova J., Lukas J. The retinoblastoma protein pathway in cell cycle control and cancer. Experimental Cell Research. 237:1997;1-6.
23. Connell-Crowley L., Harper J.W., Goodrich D.W. Cyclin D1/Cdk4 regulates retinoblastoma protein-mediated cell cycle arrest by site-specific phosphorylation. Mol. Biol. Cell. 8:1997;287-301.
24. Sellers W.R., Kaelin W.G. Role of the retinoblastoma protein in the pathogenesis of human cancer. Journal of Clinical Oncology. 15:1997;3301-3312.
25. Kaelin W.G. Alterations in G1/S cell-cycle control contributing to carcinogenesis. Annals of the New York Academy of Science. 833:1997;29-31.
26. Kornblau S.M., Andreeff M., Hu S.X.et al. Low and maximally phosphorylated levels of the retinoblastoma protein confer poor prognosis in newly diagnosed acute myelogenous leukemia: a prospective study. Clinical Cancer Research. 4:1998;1955-1963.
27. Sellers W.R., Kaelin W.G. Role of the retinoblastoma protein in the pathogenesis of human cancer. Journal of Clinical Oncology. 15:1997;3297-3298.
28. Volm M., Koomagi R., Rittgen W. Clinical implications of cyclins, cyclin-dependent kinases, Rb, and E2F1 in squamous cell lung cancer. International Journal of Cancer (Pred. Oncology). 79:1998;294-299.